Types of ELISA assays and choosing the format the analyte allows

Choosing the format

1. Check whether two binders can fit. A sandwich needs capture and detection reagents binding distinct, simultaneously accessible epitopes. Small analytes physically cannot accommodate this, which is why they are measured competitively.
2. Use competition when only one binder exists. A competitive design measures inhibition of a labelled analyte's binding, which gives an inverted curve and generally poorer precision. It is the correct choice when a sandwich is impossible, not a fallback.
3. Weigh direct against indirect detection. Direct detection with a labelled primary is faster and has fewer cross reactivity risks. Indirect detection with a labelled secondary amplifies signal and lets one secondary serve many assays. Sensitivity usually favours indirect.
4. Design capture for particles separately. Vesicles and particles are captured through surface markers and are far larger than the analytes a plate assay normally handles, which changes coating, blocking and washing. A protein assay protocol applied to them will not work.
5. Consider a kinetic read where rate carries information. Reading development over time rather than at a fixed endpoint extends dynamic range and detects wells that saturated. It requires a reader that can do it and a plan for how the rate is calculated.
6. Control washing before blaming the assay. Residual volume and inconsistent washing cause more plate assay variability than any reagent. Fix the washer and the wash protocol before optimising anything else.

The curve tells you which format you have

A sandwich assay gives a curve rising with concentration; a competitive assay gives one falling. That difference propagates into how precision behaves across the range, where the useful working region sits and how a sample near the limit should be reported.

Understanding which you have is not pedantry. It determines whether diluting an out of range sample brings it into range or pushes it further out.

Where variability actually comes from

In order: washing, pipetting, plate to plate coating differences and incubation temperature. Reagent quality is further down the list than most troubleshooting assumes.

A uniformity plate, the same sample in every well, identifies which of these is operating. It is one plate and it usually ends an argument that has been running for weeks.

Format follows the analyte's size

A sandwich format needs two antibodies binding different epitopes at once, which requires an analyte large enough to carry both. Small molecules, haptens and short peptides cannot, so they are measured competitively: the sample's analyte competes with a labelled version for a single antibody.

That inverts the signal, so a strong reading means a low concentration, and it usually gives a narrower working range. Choosing the format is not a preference: it follows from what the analyte is.

Species, the form detected, and where a his tag elisa fits

A kit raised against one species' protein frequently does not detect another's, and predicted cross-reactivity from sequence is not evidence. Kits are sold species by species for that reason, and using the wrong one produces a confident zero.

What form is detected matters as much: free against bound, precursor against mature, monomer against complex. Two kits reporting different concentrations for one sample are usually detecting different forms, and the insert is where that is stated.

Comparing kits on validation, not on price

The questions that separate kits are the standard's identity and traceability, the sensitivity and working range in your matrix, spike recovery and dilution linearity, intra and inter-assay precision, and whether validation data are shown or merely claimed.

A cheaper kit with a clean recovery in your matrix is better than an expensive one without it. Ask for the validation report and read the recovery table; that single page is the most informative part of the documentation.

What the kit does not include

Plates, wash buffer, a plate washer, a reader and often the diluent for your matrix are frequently outside the box, and substituting a wash buffer or a diluent changes the assay. Read the components list against what is actually on the bench before the study starts.

For quantitative work the reader and its qualification matter too: wavelength accuracy and linearity are part of the result. A kit validated on one reader and run on an unqualified one has lost part of its validation.

An automated elisa machine, and what it takes over

An automated ELISA processor takes the plate through dispensing, incubation, washing and reading on a schedule, which removes the two sources of variation a person introduces: inconsistent wash and drifting incubation times. Open systems run any assay you configure and closed systems run the manufacturer's own kits with a barcode, which is faster to validate and locks the reagent supply. The questions are throughput per shift with the assay you actually run, whether it handles sample dilution on board, and how the result files reach the system of record.

A psa elisa, and what a clinical shape asks for

Prostate specific antigen exists free and complexed to protease inhibitors, and a kit reports free, total or the ratio depending on its antibody pair, which is why two kits disagree on the same serum and why a result is followed within one assay rather than across assays. For any clinical use the kit has to be validated for the matrix and the instrument, with controls each run and a calibration traceable to a recognised reference preparation. For research use the same discipline costs little and makes the numbers comparable over a study.

A pcr elisa, and how the hybrid works

A PCR ELISA amplifies with a labelled primer or probe and then captures the product on a plate for a colourimetric read, which gives amplification's sensitivity with a plate reader's simplicity and no gel or fluorescence instrument. It was widely used before real time instruments became cheap and survives where a laboratory has plate readers and no thermocycler with optics, or where a specific product has to be confirmed by hybridisation. The costs are the extra handling steps and a carryover risk that an enclosed real time assay avoids.

A competitive elisa assay and when it is the right format

A competitive elisa assay is used where the analyte is too small to be bound by two antibodies at once, which is why hormones, drugs and haptens are measured this way, and its signal falls as concentration rises. That inverse curve is why its working range is narrower and why the standards matter more than in a sandwich format.

elisa reagents and what has to match

elisa reagents are a matched set rather than a list: the capture and detection antibodies must see different epitopes, the conjugate must match the detection antibody's species and the blocker must not carry the analyte. A kit exists mainly to guarantee those matches, which is what makes an assembled assay slower to validate.

Common questions

Why can't small molecules be measured in a sandwich format?

Because two antibodies cannot bind a small analyte simultaneously without interfering. Competitive formats exist precisely for this case, and their inverted curve and narrower range are inherent rather than a defect.

Are kinetic assays worth the extra time?

When the dynamic range is limiting or when wells saturate at different times, yes, because a rate is informative where an endpoint has clipped. For routine assays inside a validated range, an endpoint read is simpler and adequate.

What does the reader actually contribute?

Accurate absorbance or fluorescence at the right wavelength with good well to well uniformity. Beyond that, assay quality is set by the reagents, the plate and the washing rather than by the instrument.

How is a vesicle assay different?

Capture is on a surface marker of a particle rather than on an epitope of a soluble protein, and the analyte is heterogeneous in size and composition. Standardisation and interpretation are harder, and the controls have to reflect that.

Why would I use a competitive format?

Because the analyte is too small to bind two antibodies at once, as haptens, small molecules and short peptides are. The signal then runs inversely to concentration and the working range is usually narrower.

How do I compare two kits?

On the validation report: the standard's traceability, sensitivity and range in your matrix, spike recovery, dilution linearity and precision. A cheaper kit with clean recovery in your matrix beats an expensive one without it.

Browse by service class

• Compare Gene synthesis on advertised prices